FIELD: medicine.
SUBSTANCE: invention refers to biology and medicine, namely to immunodiagnosis. The method implies count of endothelial receptor of protein C/activated protein C (EPCR) autoantibodies in the sample. High levels of EPCR autoantibodies observed are associated with higher risk or susceptibility of an individual to development of autoimmune diseases, vascular diseases or pregnancy complications.
EFFECT: there is offered method for estimating risk of development and propensity for pathology associated with EPCR autoantibodies observed.
38 cl, 3 dwg, 3 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| DIAGNOSING GLUTEN-INDUCED AUTOIMMUNE DISEASES | 2010 |
|
RU2548730C2 |
| COMPOSITION | 2015 |
|
RU2773344C2 |
| METHOD FOR DIAGNOSIS OF ANTIPHOSPHOLIPID SYNDROME IN PATIENTS WITH THROMBOSIS AND/OR OBSTETRIC PATHOLOGY | 2022 |
|
RU2804231C1 |
| POLYPEPTIDE VARIANTS WITH CHANGED EFFECTOR FUNCTION | 2005 |
|
RU2367667C2 |
| COMPOSITION | 2015 |
|
RU2728963C2 |
| APPLICATION OF ANTI-CD40-ANTIBODIES | 2006 |
|
RU2442606C2 |
| METHOD FOR DETECTING THE RISK OF OBSTETRIC COMPLICATIONS | 2003 |
|
RU2239189C1 |
| GLA DOMAINS AS THERAPEUTIC AGENTS | 2014 |
|
RU2705786C2 |
| DECREASING B-CELL COUNT WITH USING CD37-SPECIFIC AND CD20-SPECIFIC BINDING MOLECULES | 2006 |
|
RU2423381C2 |
| METHOD FOR DETERMINING ANTI-DRUG ANTIBODY ISOTYPE | 2011 |
|
RU2574976C2 |
